Combined postoperative radiotherapy and PCV-chemotherapy (CCNU, procarbazine and vincristine) in managing anaplastic astrocytoma - A report of a long-term follow-up

I. G. Ron; N. Wigler; F. Kovner; M. Inbar; S. Chaitchik

doi:10.3892/ijo.2.6.1063

Combined postoperative radiotherapy and PCV-chemotherapy (CCNU, procarbazine and vincristine) in managing anaplastic astrocytoma - A report of a long-term follow-up

I. G. Ron^*, N. Wigler, F. Kovner, M. Inbar, S. Chaitchik

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

Abstract

Postoperative radiotherapy together with CCNU, procarbazine and vincristine (PCV-chemotherapy regimen) were analysed in patients with histologically confirmed anaplastic astrocytoma. This report evaluates the long-term survival correlated with important prognostic variables. Patients who received more than 6 courses of the PCV-chemotherapy had significantly longer survival (P=0.03). Age and performance status, identified as important prognostic factors in previous studies, are confirmed in this analysis.

Original language	English
Pages (from-to)	1063-1066
Number of pages	4
Journal	International Journal of Oncology
Volume	2
Issue number	6
DOIs	https://doi.org/10.3892/ijo.2.6.1063
State	Published - 1993
Externally published	Yes

Keywords

PCV-chemotherapy
anaplastic astrocytoma
postoperative radiotherapy
prognostic factors

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3892/ijo.2.6.1063

Cite this

@article{bb89e1e95eec495ebaba6fdf9a43aa33,

title = "Combined postoperative radiotherapy and PCV-chemotherapy (CCNU, procarbazine and vincristine) in managing anaplastic astrocytoma - A report of a long-term follow-up",

abstract = "Postoperative radiotherapy together with CCNU, procarbazine and vincristine (PCV-chemotherapy regimen) were analysed in patients with histologically confirmed anaplastic astrocytoma. This report evaluates the long-term survival correlated with important prognostic variables. Patients who received more than 6 courses of the PCV-chemotherapy had significantly longer survival (P=0.03). Age and performance status, identified as important prognostic factors in previous studies, are confirmed in this analysis.",

keywords = "PCV-chemotherapy, anaplastic astrocytoma, postoperative radiotherapy, prognostic factors",

author = "Ron, {I. G.} and N. Wigler and F. Kovner and M. Inbar and S. Chaitchik",

year = "1993",

doi = "10.3892/ijo.2.6.1063",

language = "אנגלית",

volume = "2",

pages = "1063--1066",

journal = "International Journal of Oncology",

issn = "1019-6439",

publisher = "Spandidos Publications",

number = "6",

}

TY - JOUR

T1 - Combined postoperative radiotherapy and PCV-chemotherapy (CCNU, procarbazine and vincristine) in managing anaplastic astrocytoma - A report of a long-term follow-up

AU - Ron, I. G.

AU - Wigler, N.

AU - Kovner, F.

AU - Inbar, M.

AU - Chaitchik, S.

PY - 1993

Y1 - 1993

N2 - Postoperative radiotherapy together with CCNU, procarbazine and vincristine (PCV-chemotherapy regimen) were analysed in patients with histologically confirmed anaplastic astrocytoma. This report evaluates the long-term survival correlated with important prognostic variables. Patients who received more than 6 courses of the PCV-chemotherapy had significantly longer survival (P=0.03). Age and performance status, identified as important prognostic factors in previous studies, are confirmed in this analysis.

AB - Postoperative radiotherapy together with CCNU, procarbazine and vincristine (PCV-chemotherapy regimen) were analysed in patients with histologically confirmed anaplastic astrocytoma. This report evaluates the long-term survival correlated with important prognostic variables. Patients who received more than 6 courses of the PCV-chemotherapy had significantly longer survival (P=0.03). Age and performance status, identified as important prognostic factors in previous studies, are confirmed in this analysis.

KW - PCV-chemotherapy

KW - anaplastic astrocytoma

KW - postoperative radiotherapy

KW - prognostic factors

UR - http://www.scopus.com/inward/record.url?scp=0027269897&partnerID=8YFLogxK

U2 - 10.3892/ijo.2.6.1063

DO - 10.3892/ijo.2.6.1063

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

AN - SCOPUS:0027269897

SN - 1019-6439

VL - 2

SP - 1063

EP - 1066

JO - International Journal of Oncology

JF - International Journal of Oncology

IS - 6

ER -

Combined postoperative radiotherapy and PCV-chemotherapy (CCNU, procarbazine and vincristine) in managing anaplastic astrocytoma - A report of a long-term follow-up

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this